A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

April 30, 2005

Conditions
Moderate to Severe Angina Pectoris
Interventions
GENETIC

BioBypass®

Trial Locations (3)

2100

Cardiovascular Laboratory 2014, The Heart Center, University hospital Rigshospitalet, Copenhagen

49100

Cardiac Catheterization Laboratories, Cardiology Department, Rabin Medical Center, Petah

DK-8200

Skejby Sygehus, Caridology Laboratory, Århus N

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GenVec

INDUSTRY